Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Shao

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
Protein Science : a Publication of the Protein Society|August 19, 1999
Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pHD Xie, S Gulnik, E Gustchina, et al.
Plos One|January 4, 2017
Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation PatternsXiangyuan Ma, Liangjun Zhu, Xue Wu, et al.
Blood|September 9, 2000
Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cellsW Shao, A Rosenauer, K Mann, et al.
Diabetologia|December 17, 2010
Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J miceZ Yu, W Shao, Y Chiang, et al.
Clinical Lung Cancer|April 6, 2019
Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI-Treated Non-Small-Cell Lung Cancer Revealed Using NGS-Based Liquid BiopsyMeijuan Ding, Lili Deng, Ruoying Yu, et al.
Frontiers in Oncology|August 28, 2020
Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance <i>EML4-ALK</i> Variant in Liquid Biopsy: A Case ReportYingying Zhu, Ran Jia, Yang W Shao, et al.
Japanese Journal of Clinical Oncology|August 27, 2020
EML4-ALK, a potential therapeutic target that responds to alectinib in ovarian cancerBeina Hui, Jingping Zhang, Xiaobo Shi, et al.
Animal Genetics|April 28, 2009
Development of 40 microsatellite markers in spotted halibut (Verasper variegatus) and the cross-species amplification in barfin flounder (Verasper moseri )H Y Ma, J Z Bi, C W Shao, et al.
International Journal of Cancer|August 9, 2019
Osimertinib confers potent binding affinity to EGFR kinase domain duplicationRui Jin, Jie Li, Zhou Jin, et al.
Clinical Radiology|December 24, 2008
Adult prostate sarcoma: radiological-clinical correlationF-y Ren, J-p Lu, J Wang, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
Protein Science : a Publication of the Protein Society|August 19, 1999
Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pHD Xie, S Gulnik, E Gustchina, et al.
Plos One|January 4, 2017
Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation PatternsXiangyuan Ma, Liangjun Zhu, Xue Wu, et al.
Blood|September 9, 2000
Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cellsW Shao, A Rosenauer, K Mann, et al.
Diabetologia|December 17, 2010
Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J miceZ Yu, W Shao, Y Chiang, et al.
Clinical Lung Cancer|April 6, 2019
Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI-Treated Non-Small-Cell Lung Cancer Revealed Using NGS-Based Liquid BiopsyMeijuan Ding, Lili Deng, Ruoying Yu, et al.
Frontiers in Oncology|August 28, 2020
Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance <i>EML4-ALK</i> Variant in Liquid Biopsy: A Case ReportYingying Zhu, Ran Jia, Yang W Shao, et al.
Japanese Journal of Clinical Oncology|August 27, 2020
EML4-ALK, a potential therapeutic target that responds to alectinib in ovarian cancerBeina Hui, Jingping Zhang, Xiaobo Shi, et al.
Animal Genetics|April 28, 2009
Development of 40 microsatellite markers in spotted halibut (Verasper variegatus) and the cross-species amplification in barfin flounder (Verasper moseri )H Y Ma, J Z Bi, C W Shao, et al.
International Journal of Cancer|August 9, 2019
Osimertinib confers potent binding affinity to EGFR kinase domain duplicationRui Jin, Jie Li, Zhou Jin, et al.
Clinical Radiology|December 24, 2008
Adult prostate sarcoma: radiological-clinical correlationF-y Ren, J-p Lu, J Wang, et al.
Pageof 22